{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T10:21:19Z","timestamp":1780482079241,"version":"3.54.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2002,4,1]],"date-time":"2002-04-01T00:00:00Z","timestamp":1017619200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2002,4,1]],"date-time":"2002-04-01T00:00:00Z","timestamp":1017619200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2002,4]]},"DOI":"10.1023\/a:1014913708916","type":"journal-article","created":{"date-parts":[[2002,12,28]],"date-time":"2002-12-28T21:55:50Z","timestamp":1041112550000},"page":"255-263","source":"Crossref","is-referenced-by-count":8,"title":["Sensitivity of p53-Deficient Cells to Oxaliplatin and Thio-TEPA (N, N\u2032, N\u2033 Triethylenethiophosphoramide)"],"prefix":"10.1007","volume":"72","author":[{"given":"Young R.","family":"Seo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edmund I-T","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin L.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"393836_CR1","doi-asserted-by":"crossref","unstructured":"Lowe SW, Ruley HE, Jacks T, Housman DE: p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell: 957\u2013967, 1993","DOI":"10.1016\/0092-8674(93)90719-7"},{"key":"393836_CR2","first-page":"5824","volume":"54","author":"S Fan","year":"1994","unstructured":"Fan S, el-Deiry WS, Bae I, Freeman J, Jondle D, Bhatia K, Fornace Jr AJ, Magrath I, Kohn KW, O'Connor PM: P53 gene mutations are associated with decreased sensitivity of human lymphoma cells to DNA damaging agents. Cancer Res 54: 5824\u20135830, 1994","journal-title":"Cancer Res"},{"key":"393836_CR3","first-page":"1391","volume":"59","author":"JM Brown","year":"1999","unstructured":"Brown JM, Wouters BG: Apoptosis, p53, and tumor cell sensitivity to anticancer agents. Cancer Res 59: 1391\u20131399, 1999","journal-title":"Cancer Res"},{"key":"393836_CR4","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1093\/carcin\/17.7.1417","volume":"17","author":"JM Gudas","year":"1996","unstructured":"Gudas JM, Nguyen H, Li T, Sadzewicz L, Robey R, Wosikowski K, Cowan KH: Drug-resistant breast cancer cells frequently retain expression of a functional wild-type p53 protein. Carcinogenesis 17: 1417\u20131427, 1996","journal-title":"Carcinogenesis"},{"key":"393836_CR5","first-page":"1395","volume":"6","author":"K Wosikowski","year":"1995","unstructured":"Wosikowski K, Regis JT, Robey RW, Alvarez M, Buters JT, Gudas JM, Bates SE: Normal p53 status and function despite the development of drug resistance in human breast cancer cells. Cell Growth Differ 6: 1395\u20131403, 1995","journal-title":"Cell Growth Differ"},{"key":"393836_CR6","first-page":"1649","volume":"55","author":"S Fan","year":"1995","unstructured":"Fan S, Smith ML, Rivet DJ, Duba D, Zhan Q, Kohn KW, Fornace Jr AJ, O'Connor PM: Disruption of p53 function sensitizes breast cancer MCF7 cells to cisplatin and pentoxifylline. Cancer Res 55: 1649\u20131654, 1995","journal-title":"Cancer Res"},{"key":"393836_CR7","doi-asserted-by":"crossref","first-page":"7829","DOI":"10.1073\/pnas.92.17.7829","volume":"92","author":"C Xu","year":"1995","unstructured":"Xu C, Meinkrantz W, Schlegel R, Sager R: The human papillomavirus 16E6 gene sensitizes human mammary epithelial cells to mitomycin C. Proc Natl Acad Sci USA 92: 7829\u20137833, 1995","journal-title":"Proc Natl Acad Sci USA"},{"key":"393836_CR8","first-page":"892","volume":"56","author":"DS Hawkins","year":"1996","unstructured":"Hawkins DS, Demers GW, Galloway DA: Inactivation of p53 enhances sensitivity to multiple chemotherapeutic agents. Cancer Res 56: 892\u2013898, 1996","journal-title":"Cancer Res"},{"key":"393836_CR9","doi-asserted-by":"crossref","first-page":"3705","DOI":"10.1128\/MCB.20.10.3705-3714.2000","volume":"20","author":"ML Smith","year":"2000","unstructured":"Smith ML, Ford JM, Hollander MC, Bortnick RA, Amundson SA, Seo YR, Deng C, Hanawalt PC, Fornace Jr AJ: P53-mediated DNA repair responses to UV-radiation: studies of mouse cells lacking p53, p21 and\/or gadd45 genes. Mol Cell Biol 20: 3705\u20133714, 2000","journal-title":"Mol Cell Biol"},{"key":"393836_CR10","doi-asserted-by":"publisher","first-page":"1912","DOI":"10.1038\/sj.bjc.6690620","volume":"80","author":"G Pratesi","year":"1999","unstructured":"Pratesi G, Perego P, Polizzi D, Righetti SC, Supino R, Caserini C, Manzotti C, Giuliani FC, Pezzoni G, Tognella S, Spinelli S, Farrell N, Zunino F: A novel charged trinuclear platinum complex effective against cisplatin-resistant tumours: hypersensitivity of p53-mutant human tumour xenografts. Br J Cancer 80: 1912\u20131919, 1999","journal-title":"Br J Cancer"},{"key":"393836_CR11","first-page":"2155","volume":"60","author":"EMJJ Berns","year":"2000","unstructured":"Berns EMJJ, Foekens J, Vossen R, Look M, Devilee P, Henzen-logmans S, van Staveren I, van Putten WLJ, Inganas M, Meijer-van Gelder M, Cornelisse C, Classen C, Portengen H, Bakker B, Klijn JGM: Complete sequencing of p53 predicts poor response to systemic therapy of advanced breast cancer. Cancer Res 60: 2155\u20132162, 2000","journal-title":"Cancer Res"},{"key":"393836_CR12","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1128\/MCB.19.3.1673","volume":"19","author":"F Carrier","year":"1999","unstructured":"Carrier F, Georgel PT, Pourquier P, Blake M, Kontny HU, Antinore MJ, Gariboldi M, Myers TG, Weinstein JN, Pommier Y, Fornace Jr AJ: Gadd45, a p53-responsive stress protein, modifies DNA accessibility on damaged chromatin. Mol Cell Biol 19: 1673\u20131685, 1999","journal-title":"Mol Cell Biol"},{"key":"393836_CR13","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1073\/pnas.96.2.424","volume":"96","author":"BJ Hwang","year":"1999","unstructured":"Hwang BJ, Ford JM, Hanawalt PC, Chu G: Expression of the p48 xeroderma pigmentosum gene is p53-dependent and is involved in global genomic repair. Proc Natl Acad Sci USA 96: 424\u2013428, 1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"393836_CR14","first-page":"1053","volume":"10","author":"ML Smith","year":"1995","unstructured":"Smith ML, Chen I-T, Zhan Q, O'Connor PM, Fornace Jr AJ: Involvement of the p53 tumor suppressor in repair of UV-type DNA damage. Oncogene 10: 1053\u20131059, 1995","journal-title":"Oncogene"},{"key":"393836_CR15","doi-asserted-by":"crossref","first-page":"8876","DOI":"10.1073\/pnas.92.19.8876","volume":"92","author":"JM Ford","year":"1995","unstructured":"Ford JM, Hanawalt PC: Li-Fraumeni syndrome fibroblasts homozygous for p53 mutations are deficient in global DNA repair but exhibit normal transcription-coupled repair and enhanced UV resistance. Proc Natl Acad Sci USA 92: 8876\u20138880, 1995","journal-title":"Proc Natl Acad Sci USA"},{"key":"393836_CR16","doi-asserted-by":"crossref","first-page":"28073","DOI":"10.1074\/jbc.272.44.28073","volume":"272","author":"JM Ford","year":"1997","unstructured":"Ford JM, Hanawalt PC: Expression of wild-type p53 is required for efficient global genomic nucleotide excision repair in UV-irradiated human fibroblasts. J Biol Chem 272: 28073\u201328080, 1997","journal-title":"J Biol Chem"},{"key":"393836_CR17","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/S0026-895X(24)12775-7","volume":"56","author":"J Fan","year":"1999","unstructured":"Fan J, Bertino J: Modulation of cisplatinum cytotoxicity by p53: effect of p53-mediated apoptosis and DNA repair. Mol Pharmacol 56: 966\u2013972, 1999","journal-title":"Mol Pharmacol"},{"key":"393836_CR18","first-page":"4360","volume":"51","author":"NA Cohen","year":"1991","unstructured":"Cohen NA, Egorin MJ, Snyder SW, Ashar B, Wietharn BE, Pan SS, Ross DD, Hilton J: Interaction of N, N_, N__-triethylenethiophosphoramide and N, N_, N__-phosphoramide withn cellular DNA. Cancer Res 51: 4360\u20134366, 1991","journal-title":"Cancer Res"},{"key":"393836_CR19","first-page":"88","volume":"61","author":"H Offer","year":"2001","unstructured":"Offer H, Zurer I, Banfalvi G, Reha'k M, Falcovitz A, Milyavsky M, Goldfinger N, Rotter V: P53 modulates base excision repair activity in a cell-cycle specific manner after genotoxic stress. Cancer Res 61: 88\u201396, 2001","journal-title":"Cancer Res"},{"key":"393836_CR20","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1093\/emboj\/20.4.914","volume":"20","author":"J Zhou","year":"2001","unstructured":"Zhou J, Ahn J, Wilson SH, Prives C: A role for p53 in base excision repair. EMBO J 20: 914\u2013923, 2001","journal-title":"EMBO J"},{"key":"393836_CR21","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1006\/excr.1999.4606","volume":"252","author":"D Uberti","year":"1999","unstructured":"Uberti D, Schwartz D, Almog N, Goldfinger N, Harmelin A, Memo M, Rotter V: Epithelial cells of different organs exhibit distinct patterns of p53-dependent and p53-independent apoptosis following DNA insult. Exp Cell Res 252: 123\u2013133, 1999","journal-title":"Exp Cell Res"},{"key":"393836_CR22","doi-asserted-by":"publisher","first-page":"2901","DOI":"10.1038\/sj.onc.1202518","volume":"18","author":"J Frenkel","year":"1999","unstructured":"Frenkel J, Sherman D, Fein A, Schwartz D, Almog N, Kapon A, Goldfinger N, Rotter V: Accentuated apoptosis in normally developing p53 knockout mouse embryos following genotoxic stress. Oncogene 18: 2901\u20132907, 1999","journal-title":"Oncogene"},{"key":"393836_CR23","first-page":"213","volume":"9","author":"JM Brown","year":"1997","unstructured":"Brown JM: NCI's anticancer drug screening program may not be selecting for clinically active compounds. Oncol Res 9: 213\u2013215, 1997","journal-title":"Oncol Res"},{"key":"393836_CR24","first-page":"599","volume":"58","author":"JM Ford","year":"1998","unstructured":"Ford JM, Baron EL, Hanawalt PC: Human fibroblasts expressing the human papillomavirus E6 gene are deficient in global genomic nucleotide excision repair and sensitive to ultraviolet irradiation. Cancer Res 58: 599\u2013603, 1998","journal-title":"Cancer Res"},{"key":"393836_CR25","first-page":"1993","volume":"58","author":"CA Cistulli","year":"1998","unstructured":"Cistulli CA, Kaufmann WK: p53-dependent signalling sustains DNA replication and enhances clonogenic survival in 254 nm ultraviolet-irradiated human fibroblasts. Cancer Res 58: 1993\u20132002, 1998","journal-title":"Cancer Res"},{"key":"393836_CR26","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0921-8777(99)00066-X","volume":"459","author":"MA El-Mahdy","year":"2000","unstructured":"El-Mahdy MA, Hamada FM, Wani MA, Zhu Q, Wani AA: P53 degradation by HPV16-E6 preferentially affects the removal of cyclobutane pyrimidine dimers from non-transcribed strand and sensitizes mammary epithelial cells to UV-radiation. Mutat Res 459: 135\u2013145, 2000","journal-title":"Mutat Res"},{"key":"393836_CR27","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.1016\/S0006-2952(97)81490-6","volume":"52","author":"O Rixe","year":"1996","unstructured":"Rixe O, Ortuzar W, Alvarez M, Parker R, Reed E, Paull K, Fojo T: Oxaliplatin, tetraplatin, cisplatin, and carboplatin: spectrum of activity in drug-resistant cell lines of the NCI anticancer drug screen panel. Biochem Pharmacol 52: 1855\u20131865, 1996","journal-title":"Biochem Pharmacol"},{"key":"393836_CR28","first-page":"5196","volume":"58","author":"DF Grant","year":"1998","unstructured":"Grant DF, Bessho T, Reardon JT: Nucleotide excision repair of melphalan monoadducts. Cancer Res 58: 5196\u20135201, 1998","journal-title":"Cancer Res"},{"key":"393836_CR29","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1007\/s002800050504","volume":"38","author":"BS Andersson","year":"1996","unstructured":"Andersson BS, Sadeghi T, Siliciano MJ, Legerski R, Murray D: Nucleotide excision repair genes as determinants of cellular sensitivity to cyclophosphamide analogs. Cancer Chemother Pharmacol 38: 406\u2013416, 1996","journal-title":"Cancer Chemother Pharmacol"},{"key":"393836_CR30","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0027-5107(96)00200-X","volume":"373","author":"JG Hengstler","year":"1997","unstructured":"Hengstler JG, Hengst A, Fuchs J, Tanner B, Pohl J, Oesch F: Induction of DNA crosslinks and DNA strand lesions by cyclophosphamide after activation by cytochrome P4502B1. Mutat Res 373: 215\u2013223, 1997","journal-title":"Mutat Res"},{"key":"393836_CR31","first-page":"4974","volume":"61","author":"KJ Cheung","year":"2001","unstructured":"Cheung KJ, Mitchell D, Lin P, Li G: The tumor suppressor candidate p33Ing1 mediates repair of UV-damaged DNA. Cancer Res 61: 4974\u20134977, 2001","journal-title":"Cancer Res"},{"key":"393836_CR32","first-page":"4420","volume":"55","author":"PA Havre","year":"1995","unstructured":"Havre PA, Yuan J, Hedrick L, Cho KR, Glazer PM: p53 inactivation by HPV16 E6 results in increased mutagenesis in human cells. Cancer Res55: 4420\u20134424, 1995","journal-title":"Cancer Res"},{"key":"393836_CR33","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1046\/j.1365-2133.1998.02306.x","volume":"139","author":"G Li","year":"1998","unstructured":"Li G, Ho VC: P53-dependent DNA repair and apoptosis respond differently to high and low-dose ultraviolet radiation. Br J Dermatol 139: 3\u201310, 1998","journal-title":"Br J Dermatol"},{"key":"393836_CR34","doi-asserted-by":"publisher","first-page":"6163","DOI":"10.1073\/pnas.95.11.6163","volume":"95","author":"DB Zamble","year":"1998","unstructured":"Zamble DB, Jacks T, Lippard SJ: p53-dependent and-independent responses to cisplatin in mouse testicular teratocarcinoma cells. Proc Natl Acad Sci USA 95: 6163\u20136168, 1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"393836_CR35","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1002\/1097-0215(20000815)87:4<517::AID-IJC9>3.0.CO;2-B","volume":"87","author":"I Sturm","year":"2000","unstructured":"Sturm I, Papadopoulos S, Hillebrand T, Benter T, Luck HJ, Wolff G, Dorken B, Daniel PT: Impaired Bax protein expression in breast cancer: mutational analysis of the Bax and the p53 gene. Int J Cancer 87: 517\u2013521, 2000","journal-title":"Int J Cancer"},{"key":"393836_CR36","first-page":"3103","volume":"6","author":"J Sjostrum","year":"2000","unstructured":"Sjostrum J, Blomqvist C, Heikkila P, Boguslawski KV, Raisanen-Sokolowski A, Bengtsson NO, Mjaaland I, Malstrom P, Ostenstadt B, Bergh J, Wist E, Valvere V, Saksela E: Predictive value of p53, p21, and mib-1 for chemotherapy response in advanced breast cancer. Clin Cancer Res 6: 3103\u20133110, 2000","journal-title":"Clin Cancer Res"},{"key":"393836_CR37","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1023\/A:1008359722254","volume":"11","author":"JM Ferrero","year":"2000","unstructured":"Ferrero JM, Ramaioli A, Formento JL, Francoual M, Etieene MC, Peyrottes I, Ettore F, Lablanc-Talent P, Namer M, Milano G: P53 determination alongside classical prognostic factors in node-negative breast cancer: an evaluation at more than 10-year follow-up. Ann Oncol 11: 393\u2013397, 2000","journal-title":"Ann Oncol"},{"key":"393836_CR38","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/S0092-8674(00)81871-1","volume":"88","author":"AJ Levine","year":"1997","unstructured":"Levine AJ: P53, the cellular gatekeeper for growth and division. Cell 88: 323\u2013331, 1997","journal-title":"Cell"},{"key":"393836_CR39","first-page":"2256","volume":"61","author":"BK Linderholm","year":"2001","unstructured":"Linderholm BK, Lindahl T, Holmberg L, Klaar S, Lennerstrand J, Henriksson R, Bergh J: The expression of vascular endothelial growth factor correlates with mutant p53 and poor prognosis in human breast cancer. Cancer Res 61: 2256\u20132260, 2001","journal-title":"Cancer Res"},{"key":"393836_CR40","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1038\/355846a0","volume":"355","author":"D Sidransky","year":"1992","unstructured":"Sidransky D, Mikkelsen T, Schwechheimer K, Rosenblum ML, Cavanee W, Vogelstein B: Clonal expansion of p53 mutant cells is associated with brain tumour progression. Nature 355: 846\u2013847, 1992","journal-title":"Nature"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1014913708916.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1023\/A:1014913708916\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1023\/A:1014913708916","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1014913708916.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T04:33:01Z","timestamp":1750480381000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1023\/A:1014913708916"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,4]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2002,4]]}},"alternative-id":["393836"],"URL":"https:\/\/doi.org\/10.1023\/a:1014913708916","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,4]]}}}